Literature DB >> 187208

Hepatitis B surface antigen produced by a human hepatoma cell line.

G M MacNab, J J Alexander, G Lecatsas, E M Bey, J M Urbanowicz.   

Abstract

The human hepatoma cell line, PLC/PRF/5, was shown to produce hepatitis B surface antigen (HBsAg). Immunologically reactive material was present in the supernatant tissue culture medium in significant amounts, and was associated with spherical particles approximately 20 nm in diameter. The rate of antigen production by the cells was estimated at 500 ng/day/10(6) cells by reference to a purified HBsAg standard. All immunological activity was neutralized by specific antibody and the subtype was ad. The studies reported here broaden the scope of investigations on both the in vitro production of HBsAg and the association between this antigen and primary liver cancer.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 187208      PMCID: PMC2025201          DOI: 10.1038/bjc.1976.205

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; B G ACHONG; Y M BARR
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

2.  Culture of hepatitis B virus on a human cell line of hepatic origin. Preliminary results.

Authors:  J Panous-Perrin; F Rachman; A M Courouce-Pauty; J M Dupuy
Journal:  Biomedicine       Date:  1973-10-10

3.  Characterization of hepatitis B antigen polypeptides.

Authors:  C R Howard; A J Zuckerman
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

4.  Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma.

Authors:  C L Vogel; P P Anthony; N Mody; L F Barker
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321

5.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

6.  Detection of Australia antigen in human tissue culture preparations.

Authors:  V E Coyne; B S Blumberg; I Millman
Journal:  Proc Soc Exp Biol Med       Date:  1971-12

7.  Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody.

Authors:  C M Ling; L R Overby
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

8.  Carcinoma of the esophagus in Africans: establishment of a continuously growing cell line from a tumor specimen.

Authors:  E Bey; J Alexander; J M Whitcutt; J A Hunt; J H Gear
Journal:  In Vitro       Date:  1976-02

9.  Tissue and organ culture studies of hepatitis B virus.

Authors:  A J Zuckerman
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

10.  Adaptation of cells derived from human malignant tumours to growth in vitro.

Authors:  J Alexander; E Bey; J M Whitcutt; J H Gear
Journal:  S Afr J Med Sci       Date:  1976
View more
  83 in total

1.  Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy.

Authors:  L Luckenbaugh; K M Kitrinos; W E Delaney; J Hu
Journal:  J Viral Hepat       Date:  2014-11-14       Impact factor: 3.728

2.  Comparison of different hepatocyte cell lines for use in a hybrid artificial liver model.

Authors:  M Takagi; N Fukuda; T Yoshida
Journal:  Cytotechnology       Date:  1997-05       Impact factor: 2.058

3.  Subgenomic studies on hepatitis B virus DNA integrated into the genome of hepatocellular carcinoma.

Authors:  K Togawa; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-10

4.  trans-activation of viral enhancers by the hepatitis B virus X protein.

Authors:  D F Spandau; C H Lee
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

Review 5.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

6.  Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization.

Authors:  H E Blum; L Stowring; A Figus; C K Montgomery; A T Haase; G N Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

Review 7.  Hepatitis B virus infection. Current concepts of chronicity and immunity.

Authors:  G N Vyas; H E Blum
Journal:  West J Med       Date:  1984-05

Review 8.  Hepatitis B in pregnancy.

Authors:  J A Arevalo
Journal:  West J Med       Date:  1989-06

9.  Expression of hepatitis B antigens with a simian virus 40 vector.

Authors:  H Will; R Cattaneo; E Pfaff; C Kuhn; M Roggendorf; H Schaller
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

10.  Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.

Authors:  E Paoletti; B R Lipinskas; C Samsonoff; S Mercer; D Panicali
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.